当前位置: X-MOL 学术Biochip J. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Biosensing Technologies for Chronic Diseases
BioChip Journal ( IF 4.3 ) Pub Date : 2021-02-22 , DOI: 10.1007/s13206-021-00014-3
Min Park , Yun Jung Heo

Chronic diseases represent a pressing global concern and are strongly related to the modern lifestyle. Thus, maintaining chronic disease in daily life is important. Advances in the development of chronic disease biosensors could help people to diagnose diseases earlier and tightly care at home or a body site. This review covers the efforts in the field of biosensor development for two crucial chronic diseases: cardiovascular disease (CVD) and Type 2 diabetes (T2D). Concerning the CVD diagnosis, the review presents major CVD biomarkers, troponin T, troponin I, myoglobin, and creatine kinase myocardial band subform, and discusses their current status. Concerning the T2D biosensors, the review emphasizes the importance of effective CGM biosensors in preventing diabetic complications. By engaging with other vital-signal sensors, the technology could be extended to an integrated platform for personal healthcare.



中文翻译:

慢性疾病生物传感技术

慢性病代表了全球紧迫的问题,并与现代生活方式密切相关。因此,维持日常生活中的慢性病很重要。慢性疾病生物传感器的开发进展可以帮助人们及早诊断疾病,并在家中或身体部位进行严密护理。这篇综述涵盖了生物传感器开发领域中针对两种关键的慢性疾病的努力:心血管疾病(CVD)和2型糖尿病(T2D)。关于CVD诊断,该综述介绍了主要的CVD生物标志物,肌钙蛋白T,肌钙蛋白I,肌红蛋白和肌酸激酶心肌带亚型,并讨论了它们的当前状态。关于T2D生物传感器,该评论强调了有效的CGM生物传感器在预防糖尿病并发症中的重要性。通过与其他生命信号传感器配合使用,

更新日期:2021-02-22
down
wechat
bug